| Primary |
| Product Used For Unknown Indication |
33.7% |
| Drug Use For Unknown Indication |
24.9% |
| Anaesthesia |
11.6% |
| Endotracheal Intubation |
2.8% |
| Pain |
2.8% |
| Induction Of Anaesthesia |
2.5% |
| Mechanical Ventilation |
2.5% |
| Neuromuscular Blockade |
2.5% |
| Pneumonia |
2.5% |
| General Anaesthesia |
2.1% |
| Paralysis |
1.8% |
| Prophylaxis |
1.8% |
| Sedation |
1.8% |
| Surgery |
1.8% |
| Antibiotic Prophylaxis |
1.4% |
| Muscle Relaxant Therapy |
1.1% |
| Aggression |
0.7% |
| Aortic Valve Replacement |
0.7% |
| Breakthrough Pain |
0.7% |
| Hypotension |
0.7% |
|
| Drug Ineffective |
38.3% |
| Cardiac Arrest |
5.0% |
| Circulatory Collapse |
5.0% |
| Muscle Twitching |
5.0% |
| Neuromuscular Block Prolonged |
5.0% |
| Pupil Fixed |
5.0% |
| Somnolence |
5.0% |
| Angioedema |
3.3% |
| Hypotension |
3.3% |
| Overdose |
3.3% |
| Paralysis |
3.3% |
| Pyrexia |
3.3% |
| Shock |
3.3% |
| Accidental Overdose |
1.7% |
| Anaphylactic Reaction |
1.7% |
| Completed Suicide |
1.7% |
| Delayed Recovery From Anaesthesia |
1.7% |
| Drug Effect Decreased |
1.7% |
| Drug Effect Prolonged |
1.7% |
| Drug Resistance |
1.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
23.4% |
| Anaesthesia |
22.9% |
| Product Used For Unknown Indication |
13.3% |
| Induction Of Anaesthesia |
11.7% |
| General Anaesthesia |
8.1% |
| Sedation |
4.0% |
| Antibiotic Prophylaxis |
2.8% |
| Prophylaxis |
2.4% |
| Surgery |
1.7% |
| Maintenance Of Anaesthesia |
1.6% |
| Premedication |
1.5% |
| Pain |
1.1% |
| Blepharoplasty |
1.0% |
| Renal Transplant |
1.0% |
| Prosthesis Implantation |
0.7% |
| Resuscitation |
0.7% |
| Sigmoiditis |
0.7% |
| Coronary Artery Bypass |
0.6% |
| Analgesia |
0.5% |
| Bacteroides Infection |
0.5% |
|
| Drug Ineffective |
9.3% |
| Anaphylactic Shock |
8.7% |
| Hypotension |
8.7% |
| Toxic Skin Eruption |
8.7% |
| Rash |
7.6% |
| Shock |
7.6% |
| Stevens-johnson Syndrome |
7.6% |
| Tachycardia |
5.8% |
| Urticaria |
5.8% |
| Rhabdomyolysis |
5.2% |
| Cardiac Arrest |
2.9% |
| Circulatory Collapse |
2.9% |
| Laryngeal Oedema |
2.9% |
| Angioedema |
2.3% |
| Bradycardia |
2.3% |
| Cardio-respiratory Arrest |
2.3% |
| Erythema |
2.3% |
| Pyrexia |
2.3% |
| Respiratory Distress |
2.3% |
| Thrombocytopenia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.0% |
| Sedation |
8.6% |
| Drug Use For Unknown Indication |
8.2% |
| Anaesthesia |
8.0% |
| Unevaluable Event |
5.7% |
| Coronary Artery Bypass |
4.6% |
| General Anaesthesia |
3.7% |
| Premedication |
3.6% |
| Respiratory Tract Infection |
3.6% |
| Renal Transplant |
2.4% |
| Antibiotic Prophylaxis |
2.3% |
| Infection |
2.3% |
| Pneumonia |
2.2% |
| Septic Shock |
2.1% |
| Aortic Valve Replacement |
1.6% |
| Haemodynamic Instability |
1.5% |
| Analgesic Therapy |
1.3% |
| Escherichia Infection |
1.3% |
| Induction Of Anaesthesia |
1.1% |
| Polytraumatism |
1.1% |
|
| Renal Failure |
10.0% |
| Unevaluable Event |
8.2% |
| Injury |
7.3% |
| Renal Failure Acute |
7.3% |
| Anaphylactic Shock |
5.5% |
| Respiratory Failure |
5.5% |
| Ventricular Fibrillation |
5.5% |
| Anhedonia |
4.5% |
| Anxiety |
4.5% |
| Emotional Distress |
4.5% |
| Multi-organ Failure |
4.5% |
| Pain |
4.5% |
| Acute Generalised Exanthematous Pustulosis |
3.6% |
| Cerebrovascular Accident |
3.6% |
| Hypotension |
3.6% |
| Renal Impairment |
3.6% |
| Renal Injury |
3.6% |
| Urinary Tract Infection |
3.6% |
| Wheezing |
3.6% |
| Anaesthetic Complication |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
88.9% |
| Endotracheal Intubation |
5.6% |
| Stupor |
5.6% |
|
| Shock |
80.0% |
| Hypotension |
20.0% |
|
